Deep sclerectomy with MMC is safer and more effective than trabeculectomy or tube surgery, according to Dr Nitin Anand.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
How a newly defined category of IOLs can benefit patient outcomes
A new functional classification can help achieve precise vision goals
Higher Molar Dose and Its Translation into Clinical Practice
Iridex enrolls first patient in study evaluating MicroPulse technology as an adjunct to anti-VEGF therapy for DME
The study will be led by principal investigator professor Noemi Lois, MD, PhD, FRCS(Ed), FRCOphth, at Queen’s University Belfast, in over 20 clinical sites, and plans to enroll 264 patients across the UK with severe DME.
Custom matching IOLs is key to managing patient satisfaction
Johann Krüger, MD, shares insights from 26 years of experience
Myopia’s global impact, by the numbers
The global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050
A new set of guidelines for implementing interventional glaucoma
The framework covers ocular hypertension to severe progression